288 related articles for article (PubMed ID: 9035106)
1. Adenovirus dodecahedron, a new vector for human gene transfer.
Fender P; Ruigrok RW; Gout E; Buffet S; Chroboczek J
Nat Biotechnol; 1997 Jan; 15(1):52-6. PubMed ID: 9035106
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding.
Schoehn G; Fender P; Chroboczek J; Hewat EA
EMBO J; 1996 Dec; 15(24):6841-6. PubMed ID: 9003759
[TBL] [Abstract][Full Text] [Related]
3. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
4. Addition of a short peptide ligand to the adenovirus fiber protein.
Michael SI; Hong JS; Curiel DT; Engler JA
Gene Ther; 1995 Nov; 2(9):660-8. PubMed ID: 8548556
[TBL] [Abstract][Full Text] [Related]
5. An interaction between penton base and alpha v integrins plays a minimal role in adenovirus-mediated gene transfer to hepatocytes in vitro and in vivo.
Hautala T; Grunst T; Fabrega A; Freimuth P; Welsh MJ
Gene Ther; 1998 Sep; 5(9):1259-64. PubMed ID: 9930328
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells.
Fender P; Boussaid A; Mezin P; Chroboczek J
Virology; 2005 Sep; 340(2):167-73. PubMed ID: 16040074
[TBL] [Abstract][Full Text] [Related]
7. Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage.
Di Giovine M; Salone B; Martina Y; Amati V; Zambruno G; Cundari E; Failla CM; Saggio I
Virology; 2001 Mar; 282(1):102-12. PubMed ID: 11259194
[TBL] [Abstract][Full Text] [Related]
8. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins.
Medina-Kauwe LK; Maguire M; Kasahara N; Kedes L
Gene Ther; 2001 Dec; 8(23):1753-61. PubMed ID: 11803394
[TBL] [Abstract][Full Text] [Related]
9. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
10. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
[TBL] [Abstract][Full Text] [Related]
11. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein.
Gonzalez R; Vereecque R; Wickham TJ; Vanrumbeke M; Kovesdi I; Bauters F; Fenaux P; Quesnel B
Gene Ther; 1999 Mar; 6(3):314-20. PubMed ID: 10435081
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus type 40 virions contain two distinct fibers.
Kidd AH; Chroboczek J; Cusack S; Ruigrok RW
Virology; 1993 Jan; 192(1):73-84. PubMed ID: 8517033
[TBL] [Abstract][Full Text] [Related]
13. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer.
Hong SS; Bardy M; Monteil M; Gay B; Denesvre C; Tournier J; Martin G; Eloit M; Boulanger P
Viral Immunol; 2000; 13(3):353-71. PubMed ID: 11016599
[TBL] [Abstract][Full Text] [Related]
15. The influence of adenovirus fiber structure and function on vector development for gene therapy.
Nicklin SA; Wu E; Nemerow GR; Baker AH
Mol Ther; 2005 Sep; 12(3):384-93. PubMed ID: 15993650
[TBL] [Abstract][Full Text] [Related]
16. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
[TBL] [Abstract][Full Text] [Related]
17. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
19. 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins.
Medina-Kauwe LK; Kasahara N; Kedes L
Gene Ther; 2001 May; 8(10):795-803. PubMed ID: 11420644
[TBL] [Abstract][Full Text] [Related]
20. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
